Champions Oncology Inc. (NASDAQ: CSBR) Stock Information | RedChip

Champions Oncology Inc. (NASDAQ: CSBR) Listen to this Section


$4.45
-0.0650 ( -1.44% ) 3.3K

Champions Oncology Inc is a USA based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. They derive revenue primarily from research services.

Market Data


Open


$4.45

Previous close


$4.51

Volume


3.3K

Market cap


$60.08M

Day range


$4.45 - $4.59

52 week range


$4.43 - $7.13

Insider Ownership Transactions

Total Amount Purchased: -234,108.00 | $ -1,040,610.06

Date Type Amount Purchased Purchaser
2024-04-01 Sale -135000.00 Davis Brady
2024-01-16 Buy 1000.00 Mendelson Daniel Newman
2024-01-12 Buy 2000.00 Mendelson Daniel Newman
2024-01-11 Buy 2944.00 Mendelson Daniel Newman
2024-01-10 Buy 3000.00 Mendelson Daniel Newman
2024-01-09 Buy 1000.00 Mendelson Daniel Newman
2024-01-08 Buy 3000.00 Mendelson Daniel Newman
2024-01-08 Buy 2000.00 Mendelson Daniel Newman
2024-01-05 Sale -114552.00 ACKERMAN JOEL
2024-01-04 Buy 500.00 Mendelson Daniel Newman

SEC Fillings


Form Type Description Pages Date
10-k Annual reports 77 Jul 19, 2024
8-k 8K-related 16 Jul 18, 2024
4 Insider transactions 1 Apr 01, 2024
10-q Quarterly Reports 60 Mar 15, 2024
8-k 8K-related 17 Mar 12, 2024
4 Insider transactions 1 Jan 16, 2024
4 Insider transactions 1 Jan 12, 2024
4 Insider transactions 1 Jan 11, 2024
4 Insider transactions 1 Jan 10, 2024
4 Insider transactions 1 Jan 09, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.